The role of nucleophosmin/B23 in radiation-induced chromosomal instability in human lymphoblastoid cells of different p53 genotypes

References

• Abraham RT, Acquarone M, Andersen A, Asensi A, Belle R, Berger F, Bergounioux C, Brunn G, Buquet-Fagot C, Fagot D, et al 1995. Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases. Biologie Cellulaire 83:105–120.
   PubMed Web of Science ®Google Scholar
• Allan JM, Travis LB. 2005. Mechanisms of therapy-related carcinogenesis. Nature Reviews Cancer 5:943–955.
   PubMed Web of Science ®Google Scholar
• Boutis A, Papazisis K, Pistevou-Gompaki K, Lambropoulos A, Sofroniadis I, Papageorgiou A, Destouni E, Kortsaris A. 2006. Cyclin-dependent kinase (CDK) inhibitor olomoucine enhances gamma-irradiation-induced apoptosis and cell cycle arrest in Raji cells. Anticancer Research 26:3493–3498.
   PubMed Web of Science ®Google Scholar
• Colombo E, Bonetti P, Lazzerini Denchi E, Martinelli P, Zamponi R, Marine JC, Helin K, Falini B, Pelicci PG. 2005. Nucleophosmin is required for DNA integrity and p19Arf protein stability. Molecular and Cellular Biology 25:8874–8886.
   PubMed Web of Science ®Google Scholar
• Colombo E, Marine JC, Danovi D, Falini B, Pelicci PG. 2002. Nucleophosmin regulates the stability and transcriptional activity of p53. Nature Cell Biology 4:529–533.
   PubMed Web of Science ®Google Scholar
• Cuomo ME, Knebel A, Morrice N, Paterson H, Cohen P, Mittnacht S. 2008. p53-driven apoptosis limits centrosome amplification and genomic instability downstream of NPM1 phosphorylation. Nature Cell Biology 10:723–730.
   PubMed Web of Science ®Google Scholar
• D'Assoro AB, Lingle WL, Salisbury JL. 2002. Centrosome amplification and the development of cancer. Oncogene 21:6146–6153.
   PubMed Web of Science ®Google Scholar
• Desai GR, Myerson RJ, Higashikubo R, Birnbaum E, Fleshman J, Fry R, Kodner I, Kucik N, Lacey D, Ribeiro M. 1996. Carcinoma of the rectum. Possible cellular predictors of metastatic potential and response to radiation therapy. Diseases of the Colon and Rectum 39:1090–1096.
   Google Scholar
• Enders GH, Maude SL. 2006. Traffic safety for the cell: Influence of cyclin-dependent kinase activity on genomic stability. Gene 371:1–6.
   PubMed Web of Science ®Google Scholar
• Fukasawa K. 2005. Centrosome amplification, chromosome instability and cancer development. Cancer Letters 230:6–19.
   PubMed Web of Science ®Google Scholar
• Fukasawa K. 2008. P53, cyclin-dependent kinase and abnormal amplification of centrosomes. Biochimica et Biophysica Acta 1786:15–23.
   PubMed Web of Science ®Google Scholar
• Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF. 1996. Abnormal centrosome amplification in the absence of p53. Science 271:1744–1747.
   PubMed Web of Science ®Google Scholar
• Goldberg Z. 2003. Clinical implications of radiation-induced genomic instability. Oncogene 22:7011–7017.
   PubMed Web of Science ®Google Scholar
• Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K, Pandolfi PP. 2005. Role of nucleophosmin in embryonic development and tumorigenesis. Nature 437:147–153.
   PubMed Web of Science ®Google Scholar
• Grisendi S, Mecucci C, Falini B, Pandolfi PP. 2006. Nucleophosmin and cancer. Nature Reviews Cancer 6:493–505.
   PubMed Web of Science ®Google Scholar
• Hainaut P, Hollstein M. 2000. p53 and human cancer: The first ten thousand mutations. Advances in Cancer Research 77:81–137.
   PubMed Web of Science ®Google Scholar
• Hainaut P, Wiman KG. 2009. 30 years and a long way into p53 research. The Lancet Oncology 10:913–919.
   PubMed Web of Science ®Google Scholar
• Hinchcliffe EH, Li C, Thompson EA, Maller JL, Sluder G. 1999. Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science 283:851–854.
   PubMed Web of Science ®Google Scholar
• Kawamura K, Fujikawa-Yamamoto K, Ozaki M, Iwabuchi K, Nakashima H, Domiki C, Morita N, Inoue M, Tokunaga K, Shiba N, Ikeda R, Suzuki K. 2004a. Centrosome hyperamplification and chromosomal damage after exposure to radiation. Oncology 67:460–470.
   PubMed Web of Science ®Google Scholar
• Kawamura K, Izumi H, Ma Z, Ikeda R, Moriyama M, Tanaka T, Nojima T, Levin LS, Fujikawa-Yamamoto K, Suzuki K, Fukasawa K. 2004b. Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression. Cancer Research 64:4800–4809.
   PubMed Web of Science ®Google Scholar
• Kawamura K, Morita N, Domiki C, Fujikawa-Yamamoto K, Hashimoto M, Iwabuchi K, Suzuki K. 2006. Induction of centrosome amplification in p53 siRNA-treated human fibroblast cells by radiation exposure. Cancer Science 97:252–258.
   PubMed Web of Science ®Google Scholar
• Kramer A, Neben K, Ho AD. 2002. Centrosome replication, genomic instability and cancer. Leukemia 16:767–775.
   PubMed Web of Science ®Google Scholar
• Kurki S, Peltonen K, Latonen L, Kiviharju TM, Ojala PM, Meek D, Laiho M. 2004. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 5:465–475.
   PubMed Web of Science ®Google Scholar
• Li J, Sejas DP, Burma S, Chen DJ, Pang Q. 2007. Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability. Carcinogenesis 28:1163–1170.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang X, Sejas DP, Bagby GC, Pang Q. 2004. Hypoxia-induced nucleophosmin protects cell death through inhibition of p53. Journal of Biological Chemistry 279:41275–41279.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang X, Sejas DP, Pang Q. 2005. Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells. Leukemia Research 29:1415–1423.
   PubMed Web of Science ®Google Scholar
• Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C, Salisbury JL. 2002. Centrosome amplification drives chromosomal instability in breast tumor development. Proceedings of the National Academy of Sciences of the USA 99:1978–1983.
   PubMed Web of Science ®Google Scholar
• Lingle WL, Lukasiewicz K, Salisbury JL. 2005. Deregulation of the centrosome cycle and the origin of chromosomal instability in cancer. Advances in Experimental Medicine and Biology 570:393–421.
   PubMed Web of Science ®Google Scholar
• Little JB. 2000. Radiation carcinogenesis. Carcinogenesis 21:397–404.
   PubMed Web of Science ®Google Scholar
• Little JB, Nagasawa H, Keng PC, Yu Y, Li CY. 1995. Absence of radiation-induced G1 arrest in two closely related human lymphoblast cell lines that differ in p53 status. Journal of Biological Chemistry 270:11033–11036.
   PubMed Web of Science ®Google Scholar
• Maiguel DA, Jones L, Chakravarty D, Yang C, Carrier F. 2004. Nucleophosmin sets a threshold for p53 response to UV radiation. Molecular and Cellular Biology 24:3703–3711.
   PubMed Web of Science ®Google Scholar
• Mazumder S, Gong B, Almasan A. 2000. Cyclin E induction by genotoxic stress leads to apoptosis of hematopoietic cells. Oncogene 19:2828–2835.
   PubMed Web of Science ®Google Scholar
• Murphy KL, Dennis AP, Rosen JM. 2000. A gain of function p53 mutant promotes both genomic instability and cell survival in a novel p53-null mammary epithelial cell model. FASEB Journal 14:2291–2302.
   PubMed Web of Science ®Google Scholar
• Okuda M. 2002. The role of nucleophosmin in centrosome duplication. Oncogene 21:6170–6174.
   PubMed Web of Science ®Google Scholar
• Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, Chan PK, Knudsen ES, Hofmann IA, Snyder JD, Bove KE, Fukasawa K. 2000. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell 103:127–140.
   PubMed Web of Science ®Google Scholar
• Pihan GA, Wallace J, Zhou Y, Doxsey SJ. 2003. Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Research 63:1398–1404.
   PubMed Web of Science ®Google Scholar
• Ramsamooj P, Notario V, Dritschilo A. 1995. Modification of nucleolar protein B23 after exposure to ionizing radiation. Radiation Research 143:158–164.
   PubMed Web of Science ®Google Scholar
• Saito T, Hama S, Izumi H, Yamasaki F, Kajiwara Y, Matsuura S, Morishima K, Hidaka T, Shrestha P, Sugiyama K, Kurisu K. 2008. Centrosome amplification induced by survivin suppression enhances both chromosome instability and radiosensitivity in glioma cells. British Journal of Cancer 98:345–355.
   PubMed Web of Science ®Google Scholar
• Snyder AR, Morgan WF. 2004. Radiation-induced chromosomal instability and gene expression profiling: Searching for clues to initiation and perpetuation. Mutation Research 568:89–96.
   PubMed Web of Science ®Google Scholar
• Tarapore P, Fukasawa K. 2002. Loss of p53 and centrosome hyperamplification. Oncogene 21:6234–6240.
   PubMed Web of Science ®Google Scholar
• Tokuyama Y, Horn HF, Kawamura K, Tarapore P, Fukasawa K. 2001. Specific phosphorylation of nucleophosmin on Thr(199) by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication. Journal of Biological Chemistry 276:21529–21537.
   PubMed Web of Science ®Google Scholar
• Wu MH, Yung BY. 2002. UV stimulation of nucleophosmin/B23 expression is an immediate-early gene response induced by damaged DNA. Journal of Biological Chemistry 277:48234–48240.
   PubMed Web of Science ®Google Scholar
• Xia F, Wang X, Wang YH, Tsang NM, Yandell DW, Kelsey KT, Liber HL. 1995. Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. Cancer Research 55:12–15.
   PubMed Web of Science ®Google Scholar
• Zhen W, Vaughan AT. 1995. Effect of caffeine on radiation-induced apoptosis in TK6 cells. Radiation Research 141:170–175.
   PubMed Web of Science ®Google Scholar